Search | Page 38 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:43am.

  2. Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:31am.

  3. Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:15am.

  4. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 10:47am.

  5. Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 10:43am.

  6. A Phase II Study of 5-Azacitidine and Sargramostim as Maintenance Treatment After Definitive Therapy for Poor-risk AML or MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 10:38am.

  7. Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 10:36am.

  8. Extended Dosing With Eltrombopag for Severe Aplastic Anemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... (HCV)-infection. Eltrombopag has been well-tolerated in clinical trials, and unlike recombinant TPO, it does not induce autoantibodies. ...

    Clinical Trial last updated 04/26/2016 - 9:36am.

  9. SCT Plus Immune Therapy in Average Risk AML/MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 9:52am.

  10. Study of INCB053914 in Subjects With Advanced Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/02/2016 - 4:09pm.